Quoin pharmaceuticals establishes patient specific website for ongoing netherton syndrome clinical study

Three clinical sites are now fully open; final three sites expected to open imminently three clinical sites are now fully open; final three sites expected to open imminently
QNRX Ratings Summary
QNRX Quant Ranking